(Q34531216)

English

Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

0 references

cutaneous leishmaniasis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Anette Chrusciak-Talhari

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Reynaldo Dietze

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Carolina Chrusciak Talhari

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Roberto Moreira da Silva

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Ellen Priscila Gadelha Yamashita

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Gerson de Oliveira Penna

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Paulo Roberto Lima Machado

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sinésio Talhari

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

American Journal of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

84

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

255-260

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029178

7 July 2018

Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029178

7 July 2018

Treatment of New World cutaneous leishmaniasis with miltefosine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029178

7 July 2018

Oral miltefosine for the treatment of Indian visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029178

7 July 2018

Molecular epidemiology of Leishmania (Viannia) guyanensis in French Guiana

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029178

7 July 2018

Culture-independent species typing of neotropical Leishmania for clinical validation of a PCR-based assay targeting heat shock protein 70 genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029178

7 July 2018

Current treatment approaches to leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029178

7 July 2018

Identification of antigenically distinct populations of Leishmania (Viannia) guyanensis from Manaus, Brazil, using monoclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029178

7 July 2018

Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029178

7 July 2018

The dermal leishmaniases of Brazil, with special reference to the eco-epidemiology of the disease in Amazonia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029178

7 July 2018

Characterization and classification of leishmanial parasites from humans, wild mammals, and sand flies in the Amazon region of Brazil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029178

7 July 2018

Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029178

27 October 2018

Miltefosine for new world cutaneous leishmaniasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029178

27 October 2018

Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029178

27 October 2018

Comparative assessment of the efficacy and toxicity of N-methyl-glucamine and BP88 sodium stibogluconate in the treatment of localized cutaneous leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21292895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies that distinguish subspecies of Leishmania braziliensis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21292895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[A comparative study between sodium stibogluconate BP 88R and meglumine antimoniate in the treatment of cutaneous leishmaniasis. I. The efficacy and safety]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21292895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Bolivian mucosal leishmaniasis with miltefosine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21292895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4269/AJTMH.2011.10-0155

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34531216&oldid=1777670502"